88 related articles for article (PubMed ID: 17847090)
1. Molecular docking study of the interactions between the thioesterase domain of human fatty acid synthase and its ligands.
Cheng F; Wang Q; Chen M; Quiocho FA; Ma J
Proteins; 2008 Mar; 70(4):1228-34. PubMed ID: 17847090
[TBL] [Abstract][Full Text] [Related]
2. Comparative docking of dual conformations in human fatty acid synthase thioesterase domain reveals potential binding cavity for virtual screening of ligands.
John A; Vetrivel U; Subramanian K; Deepa PR
J Biomol Struct Dyn; 2017 May; 35(6):1350-1366. PubMed ID: 27145135
[TBL] [Abstract][Full Text] [Related]
3. Modeling of Human Fatty Acid Synthase and in Silico Docking of Acyl Carrier Protein Domain and Its Partner Catalytic Domains.
Viegas MF; Neves RPP; Ramos MJ; Fernandes PA
J Phys Chem B; 2018 Jan; 122(1):77-85. PubMed ID: 29210581
[TBL] [Abstract][Full Text] [Related]
4. Computational screening of fatty acid synthase inhibitors against thioesterase domain.
Panman W; Nutho B; Chamni S; Dokmaisrijan S; Kungwan N; Rungrotmongkol T
J Biomol Struct Dyn; 2018 Nov; 36(15):4114-4125. PubMed ID: 29161996
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of FAS thioesterase domain with polyunsaturated fatty acyl adduct and inhibition by dihomo-gamma-linolenic acid.
Zhang W; Chakravarty B; Zheng F; Gu Z; Wu H; Mao J; Wakil SJ; Quiocho FA
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15757-62. PubMed ID: 21908709
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat.
Pemble CW; Johnson LC; Kridel SJ; Lowther WT
Nat Struct Mol Biol; 2007 Aug; 14(8):704-9. PubMed ID: 17618296
[TBL] [Abstract][Full Text] [Related]
7. Peptides from purified soybean beta-conglycinin inhibit fatty acid synthase by interaction with the thioesterase catalytic domain.
Martinez-Villaluenga C; Rupasinghe SG; Schuler MA; Gonzalez de Mejia E
FEBS J; 2010 Mar; 277(6):1481-93. PubMed ID: 20148945
[TBL] [Abstract][Full Text] [Related]
8. Engineering of Saccharomyces cerevisiae for the synthesis of short chain fatty acids.
Leber C; Da Silva NA
Biotechnol Bioeng; 2014 Feb; 111(2):347-58. PubMed ID: 23928901
[TBL] [Abstract][Full Text] [Related]
9. Human fatty acid synthase: structure and substrate selectivity of the thioesterase domain.
Chakravarty B; Gu Z; Chirala SS; Wakil SJ; Quiocho FA
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15567-72. PubMed ID: 15507492
[TBL] [Abstract][Full Text] [Related]
10. Effect of modification of the length and flexibility of the acyl carrier protein-thioesterase interdomain linker on functionality of the animal fatty acid synthase.
Joshi AK; Witkowski A; Berman HA; Zhang L; Smith S
Biochemistry; 2005 Mar; 44(10):4100-7. PubMed ID: 15751987
[TBL] [Abstract][Full Text] [Related]
11. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
Wei HY; Lu CS; Lin TH
J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
[TBL] [Abstract][Full Text] [Related]
12. Molecular simulations of β-lactoglobulin complexed with fatty acids reveal the structural basis of ligand affinity to internal and possible external binding sites.
Evoli S; Guzzi R; Rizzuti B
Proteins; 2014 Oct; 82(10):2609-19. PubMed ID: 24916607
[TBL] [Abstract][Full Text] [Related]
13. Ligand-induced conformational changes: improved predictions of ligand binding conformations and affinities.
Frimurer TM; Peters GH; Iversen LF; Andersen HS; Møller NP; Olsen OH
Biophys J; 2003 Apr; 84(4):2273-81. PubMed ID: 12668436
[TBL] [Abstract][Full Text] [Related]
14. Structural and dynamical aspects of Streptococcus gordonii FabH through molecular docking and MD simulations.
Shamim A; Abbasi SW; Azam SS
J Mol Graph Model; 2015 Jul; 60():180-96. PubMed ID: 26059477
[TBL] [Abstract][Full Text] [Related]
15. In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.
Gadhe CG; Balupuri A; Cho SJ
J Biomol Struct Dyn; 2015; 33(11):2491-510. PubMed ID: 25617117
[TBL] [Abstract][Full Text] [Related]
16. Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions.
Kirubakaran P; Kothandan G; Cho SJ; Muthusamy K
Mol Biosyst; 2014 Feb; 10(2):281-93. PubMed ID: 24291818
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking and dynamic simulation evaluation of Rohinitib - Cantharidin based novel HSF1 inhibitors for cancer therapy.
Agarwal T; Annamalai N; Khursheed A; Maiti TK; Arsad HB; Siddiqui MH
J Mol Graph Model; 2015 Sep; 61():141-9. PubMed ID: 26245696
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling study of the editing active site of Escherichia coli leucyl-tRNA synthetase: two amino acid binding sites in the editing domain.
Lee KW; Briggs JM
Proteins; 2004 Mar; 54(4):693-704. PubMed ID: 14997565
[TBL] [Abstract][Full Text] [Related]
19. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
Paula S; Monson N; Ball WJ
Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel antilipogenic agents targeting fatty acid biosynthesis through structure-based virtual screening.
Soulère L; Alix PM; Croze ML; Soulage CO
Chem Biol Drug Des; 2018 Jul; 92(1):1366-1372. PubMed ID: 29635861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
